Kevin Caliendo
Stock Analyst at UBS
(4.41)
# 356
Out of 5,113 analysts
199
Total ratings
70.71%
Success rate
11.51%
Average return
Main Sectors:
Stocks Rated by Kevin Caliendo
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ALHC Alignment Healthcare | Maintains: Neutral | $18 → $21 | $20.96 | +0.19% | 9 | Jan 14, 2026 | |
| MDLN Medline | Initiates: Buy | $48 | $46.31 | +3.65% | 1 | Jan 12, 2026 | |
| CVS CVS Health | Maintains: Buy | $96 → $97 | $72.00 | +34.72% | 11 | Dec 10, 2025 | |
| SOLV Solventum | Maintains: Neutral | $77 → $79 | $77.61 | +1.79% | 2 | Nov 10, 2025 | |
| LFST LifeStance Health Group | Maintains: Buy | $9 → $10 | $7.10 | +40.85% | 6 | Nov 7, 2025 | |
| COR Cencora | Maintains: Buy | $380 → $415 | $356.14 | +16.53% | 4 | Nov 7, 2025 | |
| GDRX GoodRx Holdings | Maintains: Neutral | $4.25 → $4 | $2.33 | +71.67% | 8 | Nov 6, 2025 | |
| MCK McKesson | Maintains: Buy | $920 → $980 | $834.18 | +17.48% | 17 | Nov 6, 2025 | |
| CAH Cardinal Health | Maintains: Buy | $185 → $220 | $214.04 | +2.78% | 18 | Oct 31, 2025 | |
| UNH UnitedHealth Group | Maintains: Buy | $378 → $430 | $282.70 | +52.10% | 13 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $325 → $320 | $271.12 | +18.03% | 7 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $24 → $23 | $12.77 | +80.11% | 12 | Oct 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $180 → $170 | $184.12 | -7.67% | 5 | Oct 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $180 → $190 | $184.24 | +3.13% | 16 | Oct 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $160 → $155 | $167.04 | -7.21% | 19 | Oct 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $75 → $70 | $76.87 | -8.94% | 6 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $18 → $22 | $24.11 | -8.75% | 4 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $15 | $3.40 | +341.18% | 3 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $12 → $9 | $4.64 | +93.97% | 3 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $410 → $390 | $270.09 | +44.40% | 11 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $380 → $250 | $207.93 | +20.23% | 6 | Oct 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $72 → $79 | $41.53 | +90.22% | 2 | Dec 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $610 → $575 | $322.92 | +78.06% | 1 | Jul 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $185 → $180 | $224.44 | -19.80% | 7 | Jul 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $130 → $72 | $5.91 | +1,118.27% | 4 | Mar 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $15 → $11 | $32.53 | -66.19% | 4 | May 4, 2021 |
Alignment Healthcare
Jan 14, 2026
Maintains: Neutral
Price Target: $18 → $21
Current: $20.96
Upside: +0.19%
Medline
Jan 12, 2026
Initiates: Buy
Price Target: $48
Current: $46.31
Upside: +3.65%
CVS Health
Dec 10, 2025
Maintains: Buy
Price Target: $96 → $97
Current: $72.00
Upside: +34.72%
Solventum
Nov 10, 2025
Maintains: Neutral
Price Target: $77 → $79
Current: $77.61
Upside: +1.79%
LifeStance Health Group
Nov 7, 2025
Maintains: Buy
Price Target: $9 → $10
Current: $7.10
Upside: +40.85%
Cencora
Nov 7, 2025
Maintains: Buy
Price Target: $380 → $415
Current: $356.14
Upside: +16.53%
GoodRx Holdings
Nov 6, 2025
Maintains: Neutral
Price Target: $4.25 → $4
Current: $2.33
Upside: +71.67%
McKesson
Nov 6, 2025
Maintains: Buy
Price Target: $920 → $980
Current: $834.18
Upside: +17.48%
Cardinal Health
Oct 31, 2025
Maintains: Buy
Price Target: $185 → $220
Current: $214.04
Upside: +2.78%
UnitedHealth Group
Oct 29, 2025
Maintains: Buy
Price Target: $378 → $430
Current: $282.70
Upside: +52.10%
Oct 29, 2025
Maintains: Buy
Price Target: $325 → $320
Current: $271.12
Upside: +18.03%
Oct 28, 2025
Maintains: Buy
Price Target: $24 → $23
Current: $12.77
Upside: +80.11%
Oct 24, 2025
Maintains: Neutral
Price Target: $180 → $170
Current: $184.12
Upside: -7.67%
Oct 17, 2025
Maintains: Neutral
Price Target: $180 → $190
Current: $184.24
Upside: +3.13%
Oct 16, 2025
Maintains: Neutral
Price Target: $160 → $155
Current: $167.04
Upside: -7.21%
Aug 6, 2025
Maintains: Neutral
Price Target: $75 → $70
Current: $76.87
Upside: -8.94%
Jul 29, 2025
Maintains: Neutral
Price Target: $18 → $22
Current: $24.11
Upside: -8.75%
May 9, 2025
Maintains: Buy
Price Target: $14 → $15
Current: $3.40
Upside: +341.18%
May 8, 2025
Maintains: Neutral
Price Target: $12 → $9
Current: $4.64
Upside: +93.97%
Feb 3, 2025
Maintains: Buy
Price Target: $410 → $390
Current: $270.09
Upside: +44.40%
Oct 4, 2024
Maintains: Neutral
Price Target: $380 → $250
Current: $207.93
Upside: +20.23%
Dec 21, 2023
Maintains: Neutral
Price Target: $72 → $79
Current: $41.53
Upside: +90.22%
Jul 13, 2023
Maintains: Buy
Price Target: $610 → $575
Current: $322.92
Upside: +78.06%
Jul 21, 2022
Maintains: Neutral
Price Target: $185 → $180
Current: $224.44
Upside: -19.80%
Mar 8, 2022
Maintains: Neutral
Price Target: $130 → $72
Current: $5.91
Upside: +1,118.27%
May 4, 2021
Downgrades: Neutral
Price Target: $15 → $11
Current: $32.53
Upside: -66.19%